Delivery Order SPE2DB22D2211-SPE2DB25FSCYE
- Not listed
- The Defense Logistics Agency awarded a $3,580.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on August 19, 2025. The contract, designated as a non-set-aside competitive award, is scheduled for completion by September 10, 2025, with performance taking place at the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,580.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. This non-set-aside contract is scheduled for completion by September 9, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, will fulfill this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,685.66 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 ml syringes. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be completed by August 28, 2025, with the contract issued on August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- This is a $7,161.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KINERET 100 MG/0.67 ML SYRINGE 0.67ML medical products, with a period of performance through April 9, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,371.32 firm fixed-price delivery order is for the provision of Kineret 100 mg/0.67 ml syringes. The contract has a period of performance through July 17, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,228.64 firm fixed-price delivery order is for the supply of KINERET 100 MG/0.67 ML SYRINGE 0.67ML, a specialty pharmaceutical product, to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,580.88, is for the delivery of KINERET 100 MG/0.67 ML SYRINGE 0.67ML medical supplies. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of a specific pharmaceutical product - Kineret 100 mg/0.67 ml syringe. The contract is a Delivery Order with a Firm Fixed Price type, valued at $1,614.32, and has an ultimate completion date of July 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Kineret 100 mg/0.67 ml syringes to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The $3,228.64 firm fixed price delivery order was awarded on June 5, 2024 and has a completion date of June 27, 2024. The contract is not set aside and is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,380.62 firm fixed-price delivery order is for the supply of 4,561,232,022 units of the medication Kineret 100 mg/0.67 mL syringe. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCYEDelivery Order
The Defense Logistics Agency awarded a $3,580.88 delivery order to AmerisourceBergen Drug Corp for Kineret (anakinra) 100 mg/0.67 mL syringes on August 14, 2025, with a completion date of September 5, 2025. This firm fixed-price contract, which carries no set-aside designation, reflects a competitive award to the pharmaceutical distributor for delivery to its corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a critical federal pharmaceutical vendor specializing in medical supply chain support for military and veteran healthcare systems. The $999.9 billion prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally, including specialty medications, vaccines, syringes, and other critical medical commodities across multiple therapeutic domains. This delivery order for Kineret, a biologic immunosuppressant used in rheumatoid arthritis treatment, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for Defense Health Agency operations and other federal healthcare systems through a flexible contract structure designed to support military medical programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/14/25 |